Wegovy vs Zepbound for Women Over 50: A Complete Comparison Guide

If you're a woman over 50 considering medical weight loss options, you've likely heard about Wegovy and Zepbound. These two medications have transformed how we approach weight management, but choosing between them can feel overwhelming, especially when you're navigating hormonal changes, metabolism shifts, and other health considerations that come with this stage of life.

Both medications are FDA-approved for chronic weight management, but they work slightly differently and may offer distinct advantages depending on your individual health profile. Let's break down what you need to know to have an informed conversation with your healthcare provider.

Understanding the Basics: What Are Wegovy and Zepbound?

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a hormone your body naturally produces to regulate appetite and blood sugar. It's been available longer and has an established track record for weight loss.

Zepbound contains tirzepatide, which is a dual-action medication. It activates both GLP-1 and GIP receptors, potentially offering enhanced metabolic benefits. Think of it as working through two channels instead of one.

Both medications are given as weekly injections, and both work by reducing appetite, slowing digestion, and helping you feel fuller longer.

How Effective Are They for Women Over 50?

Clinical trial data shows impressive results for both medications, though Zepbound has shown slightly higher average weight loss in head-to-head comparisons.

In studies, Wegovy users lost an average of 15-17% of their body weight over 68 weeks. Zepbound users saw even more dramatic results, with average weight loss ranging from 15% to 22.5%, depending on the dose.

What About Menopausal Women Specifically?

While both medications have been studied in women over 50, it's worth noting that postmenopausal women often face unique challenges with weight loss due to hormonal changes, decreased muscle mass, and slower metabolism.

The good news is that GLP-1 medications appear to be effective regardless of menopausal status. Some women report that these medications help counteract the stubborn weight gain that often accompanies perimenopause and menopause.

Neither medication directly addresses hormonal changes, but by improving insulin sensitivity and reducing inflammation, they may help with some metabolic challenges that intensify after 50.

Side Effects: What to Expect

Both Wegovy and Zepbound share similar side effects since they work on related pathways. The most common issues include nausea, diarrhea, constipation, and occasional vomiting, especially when starting or increasing doses.

For women over 50, there are a few additional considerations:

• Bone health: Rapid weight loss can potentially affect bone density, which is already a concern for postmenopausal women. Your doctor may recommend calcium and vitamin D supplementation.
• Muscle preservation: Maintaining muscle mass becomes more important with age. Combining these medications with resistance training and adequate protein intake is crucial.
• Gallbladder issues: Risk of gallstones may increase with rapid weight loss, something to monitor regardless of age.

Some patients report that Zepbound may cause slightly more gastrointestinal discomfort initially, though this varies considerably between individuals.

Which One Is Right for You?

The choice between Wegovy and Zepbound isn't always straightforward. Several factors might influence your decision:

Consider Wegovy If:

• You prefer a medication with a longer track record
• You have a history of gastrointestinal sensitivity
• Your insurance covers Wegovy but not Zepbound
• You're looking for established research specifically in your demographic

Consider Zepbound If:

• You're looking for potentially greater weight loss results
• You have type 2 diabetes or prediabetes (the dual action may offer additional metabolic benefits)
• You haven't achieved desired results with GLP-1-only medications
• Your healthcare provider believes the dual-action approach suits your metabolic profile

Cost and Accessibility

Both brand-name medications carry similar list prices, typically ranging from $900 to $1,300 per month without insurance. Insurance coverage varies widely, and many plans require prior authorization or step therapy.

Compounded versions of semaglutide and tirzepatide have become increasingly available through specialized telehealth providers, offering more affordable access to these medications at a fraction of the brand-name cost.

Special Considerations for Women Over 50

When starting any weight loss medication after 50, work closely with your healthcare provider to monitor several key areas:

Your cardiovascular health becomes increasingly important. Both medications have shown cardiovascular benefits in studies, but individual monitoring is essential, especially if you have existing heart conditions or risk factors.

Medication interactions matter more as we tend to take more medications with age. Be sure your doctor reviews your complete medication list, including supplements.

Realistic goal-setting is crucial. While these medications are highly effective, results may vary, and slower, steady weight loss is often healthier for this age group than rapid drops.

From the Ozari Care Team

When working with women over 50, we often recommend starting at the lowest effective dose and titrating slowly to minimize side effects. It's also essential to pair any GLP-1 medication with strength training at least twice weekly to preserve muscle mass during weight loss, which becomes increasingly important for metabolic health and functional independence as we age.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026